IT IS GENERALLY ACCEPTED IN the clinic that after lung resection in adults, the residual lung increases in volume to some extent, but that this increase is primarily hyperinflation with minimal recovery, and possibly even deterioration in lung function (16) . In contrast, compensatory lung growth after lung resection has been reported in children (24) and in many animal models, including mice (7, 33) . While this compensatory lung growth potential may be completely lost in the adult human lung, there is also evidence to suggest that the adult lung may, at least in part, regain its growth potential under certain conditions (5, 32) Developing research in tissue engineering and regeneration may some day accomplish the assembly of functional lung tissue ex vivo, but for the mean time, facilitation of compensatory lung growth in the residual lung may be a more attainable goal to improve residual lung function after resection.
The combination of dexamethasone (10 nM), 8-bromo-3=-5=-cyclic adenosine monophosphate (cAMP) (0.1 mM), and isobutylmethylxanthine (0.1 mM), referred to as DCI, has been reported to optimally induce cell differentiation in fetal lung explants and fetal lung cells (2, 8) , as well as to maintain differentiation in already differentiated type II epithelial cells (3) . The effects of DCI seem to be derived from the combination of dexamethasone and elevation of cAMP, but the exact mechanisms remain unclear.
DCI administration is known to modulate the expression levels of many genes in pulmonary epithelial cells. These include keratinocyte growth factor receptor and estrogen receptor (15) , which have both been reported to be involved in the facilitation of lung growth in response to lung resection or various forms of lung injury. Recently, we found that RNA silencing of thyroid transcription factor 1 (TTF-1) delayed compensatory lung growth (31) . DCI is also known to induce TTF-1 in pulmonary epithelial cells (15) . From these findings, we hypothesized that DCI administration may facilitate compensatory lung growth. In the present study, using a mouse postpneumonectomy lung growth model, we observed the effects of DCI administration through the airway on compensatory lung growth.
MATERIALS AND METHODS
Animal experiments. Specific pathogen-free, 9-wk-old, inbred, male C57BL/6 mice, weighing ϳ20 g, were purchased from CLEA Japan, (Tokyo, Japan). The mice were kept in a 12:12-h light-dark cycle with free access to food and water.
The mice were randomly assigned to three experimental groups, left pneumonectomy (PNX) under mechanical ventilation followed by administration of DCI in Infasurf (PNXϩDCI group), left pneumonectomy under mechanical ventilation followed by administration of Infasurf alone (PNXϩINF group), or 9-wk-old male mice without any surgical interventions or treatment administration (NoTx group).
For left pneumonectomy, the mice were anesthetized with 100 mg/kg of ketamine and 10 mg/kg of xylazine administered subcutaneously. They were intubated with an 18-gauge catheter and connected to a rodent ventilator, adjusted to maintain a respiratory rate of 100 breaths/min, 10 ml/kg tidal volume, 2 cmH 2O positive endexpiratory pressure, and 0.21 inspired oxygen. A 20-mm-long postero-lateral skin incision was made, followed by thoracotomy in the fifth intercostal space with dissection of the serratus anterior and latissimus dorsi muscles. Left pneumonectomy was done by resecting the whole left lung from the pleural cavity. The left main bronchus with left pulmonary artery and vein were ligated at the hilum with a 5-0 silk suture before removal of the lung. The tidal volume was reduced from 10 to 6 ml/kg after the lung was removed. The fifth intercostal space was closed with a single surgical suture, and the skin and muscle incisions were closed with two sutures to avoid excessive tension on the muscles. The duration of mechanical ventilation for the whole surgical procedure was ϳ10 min. All mice recovered quickly after termination of mechanical ventilation and were promptly extubated.
After left pneumonectomy, DCI, a mixture of dexamethasone (500 ng/g; Sigma), 8-bromo-cAMP (5 g/g; Santa Cruz Biotechnology, Santa Cruz, CA), and 3-isobutyl-1-methylxanthine (12.5 g/g; Cal-biochem, La Jolla, CA), was administered intranasally, as previously reported (18) , with Infasurf (15 g/g; Ony, Amherst, New York) as a surface-active material (INFϩDCI group). Infasurf alone was administered as a control (INF group). The in vivo dosage of DCI was extrapolated from the previously reported in vitro data (15) , in vivo data (18, 36) , and from our own experiences in the comparisons of in vitro vs. in vivo gene silencing using siRNAs. Administration into the nasal orifices was done using a microliter pipetter as a total of ϳ25 l. The administration was done ϳ30 min after extubation in both groups, at which time the mice had sufficiently recovered breathing but were still immobilized. Nine-week-old male mice without any surgical interventions or treatment were also evaluated as NoTx group.
The mice were weighed and were observed daily for any signs of distress or changes in behavior. The mice were killed at indicated time points by injection of 100 mg/kg of ketamine and 10 mg/kg of xylazine, followed by exsanguination from the inferior vena cava. The right lung was resected at designated time points for histology or Western blot analysis, as described previously.
All experimental protocols were reviewed by the Committee on the Ethics of Animal Experiments at the School of Medicine, Keio University, and were carried out in accordance with Guidelines for Animal Experiments, issued by the School of Medicine, Keio University Experimental Animal Center.
Morphological analyses. For morphological analyses, the right lung was inflated with intratracheal instillation of 10% buffered formalin at a pressure of 20 cmH 2O. The trachea was tied under pressure, and the lung was fixed in the chest cavity for 48 h before removal. Total right lung volume was measured from the fixed specimen by volume displacement, as described by Scherle (29) as the lung volume (LV) and was also normalized to the body weight as lung volume index (LVI). The lung tissue was then embedded in paraffin and cut sagitally in 4-m sections. Hematoxylin-and-eosin staining was done for histological analyses. Alveolus area was traced and calculated using Image J. Morphologically, alveoli were identified as polyhedral, cup, or wedged-shaped terminal air spaces with discrete septae, whereas terminal, somewhat elongated air spaces from which alveoli emerged, were considered as alveolar ducts (9) . The alveolar surface area per unit of lung volume (SVw) was measured, as previously described by Weibel (34) and Kawakami et al. (10) . Briefly, a standard line of the same length (LT) was drawn on the field, and intersections with this line were counted (Iw). SVw was calculated as SVw ϭ 2 Iw/LT. For each analysis, one section was randomly selected per animal, and 5,200-fold magnification fields were randomly selected per section. The slides were coded and masked for identity and were examined by Y. Takahashi and E. Ikeda.
Lung weight measurements. The lung weight was measured as a gross assessment of compensatory lung growth. The resected lungs were lightly patted dry, weighed, and normalized to the body weight as the lung wet weight index (LWWI). The resected lungs were also completely dried in a vacuum drying oven (DP22; Yamato Scientific, Tokyo, Japan) at 95°C, and at Ϫ270 cmH 2O for 48 h, and then were weighed as the lung dry weight (LDW) and was also normalized to the body weight as the lung dry weight index (LDWI).
Transpulmonary pressure measurements. Transpulmonary pressures were measured in separate groups of animals by modifying previously reported methods (14, 30) . The animals were killed by injection of 100 mg/kg of ketamine and 10 mg/kg of xylazine, followed by exsanguination from the inferior vena cava, 14 days after interventions in PNX (n ϭ 5), PNXϩINF (n ϭ 5), and PNXϩDCI (n ϭ 5) groups. The animal was intubated, and the intubation tube was connected to an injection syringe and a water manometer (Innomedics Medical Instruments, Tokyo, Japan) by a three-way stopcock. The diaphragm was observed through the laparotomy. The lung was assumed to be at functional residual capacity after death, which was in agreement with the position of the diaphragm observed through the laparotomy. The lung was inflated by air at 0.1-ml increments, up to maximum inspiration observed by the position of the diaphragm, and then it was derecruited by deflation at 0.1-ml increments. Lung deflation was observed through the diaphragm. Intratracheal pressure during deflation was measured by the water manometer as the transpulmonary pressure. Static compliance was calculated as the slope of the curve from 0 to 5 cmH 2O of transpulmonary pressure.
Western blot analysis for TTF-1. For TTF-1 Western blot analysis, the right lung was resected at respective time points, blotted dry, immediately snap frozen in liquid nitrogen, and stored in Ϫ80°C. Western blot analysis for TTF-1 protein was performed according to a standard protocol. Briefly, lung tissue was lysed with a denaturing RIPA buffer (Sigma, Stockholm, Sweden), and the lysate was centrifuged at 14,000 rpm for 15 min at 4°C, and the supernatant was mixed with Laemmli buffer and applied to SDS-PAGE gels. The proteins were separated by 12.5% SDS-PAGE under reducing conditions and then transferred to PVDF membrane for 90 min at 90 V using HorizBlot system (ATTO, Tokyo, Japan). After blocking nonspecific reactions with Block Ace (Dainippon Pharmaceutical, Osaka, Japan), the primary antibody for TTF-1 (H-190: Santa Cruz Biotechnology, Santa Cruz, CA) and the antibody for ␤-actin (Abcam, Cambridge, UK) were incubated with the blot overnight at 4°C. The secondary anti-rabbit IgG: ECL anti-rabbit IgG horseradish peroxidase linked with whole antibody (GE Healthcare, Little Chalfont, Buckinghamshire, UK) was incubated with the blots for 1 h at room temperature. Fig. 1 . Changes in lung volume index and lung weight index after pneumonectomy and administration of a combination of dexamethasone, 8-bromo-3=-5=-cyclic adenosine monophosphate, and isobutylmethylxanthine (DCI). A: overall, the body weight of the mice was increased over time reflecting growth. The body weight of the mice was reduced in the left pneumonectomy (PNX)ϩDCI (n ϭ 5) and PNXϩ administration of Infasurf alone (INF; n ϭ 5) groups compared with the NoTx (n ϭ 5) group beyond day 2, but statistical significance was not reached. The body weight of the mice did not differ significantly between the PNXϩDCI group and the PNXϩINF group throughout the experiment period. *P Ͻ 0.05 vs. day 0 of the same group. B: residual right lung volume index (LV) was increased significantly beyond day 2 in both the PNXϩDCI (n ϭ 5 at each time point ) group and the PNXϩINF (n ϭ 5 at each time point) group compared with the NoTx (n ϭ 5 at each time point) group. Within the PNXϩDCI group and the PNXϩINF group, there were no statistically different increases beyond day 2. There was no statistical difference in LV between the PNXϩDCI group and the PNXϩINF group. *P Ͻ 0.05 vs. NoTx group. C: residual right lung volume index (LVI) was increased significantly beyond day 2 in both the PNXϩDCI (n ϭ 5 at each time point) group and the PNXϩINF (n ϭ 5 at each time point) group compared with the NoTx (n ϭ 5 at each time point) group. Within the PNXϩDCI group and the PNXϩINF group, there were no statistically different increases beyond day 2. There was no statistical difference in LVI between the PNXϩDCI group and the PNXϩINF group. *P Ͻ 0.05 vs. NoTx group. D: residual right lung dry weight (LDW) was significantly increased in the PNXϩDCI (n ϭ 5 at each time point) group compared with the PNXϩINF (n ϭ 5 at each time point) group and the NoTx (n ϭ 5 at each time point) group beyond day 2. *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups. E: residual right lung dry weight index (LDWI) was significantly increased in the PNXϩDCI (n ϭ 5 at each time point) group compared with the PNXϩINF (n ϭ 5 at each time point) group and the no treatment (NoTx; n ϭ 5 at each time point) group beyond day 2. *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups. F: residual right lung wet weight index (LWWI) tended to be higher in the PNXϩDCI (n ϭ 5) group compared with the PNXϩINF (n ϭ 5 at each time point) group and the NoTx (n ϭ 5 at each time point) group beyond day 2. *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups. G: LDWI at day 14 was compared between different dosages of DCI (n ϭ 5 in each group). One quarter, one half, and twofold amounts were administered. The twofold dose did not induce further increase in LDWI, while one-half or one-quarter dosage attenuated the increase in LDWI. Hence, the dosage used in this study was considered to be most suitable within the dosages evaluated. *P Ͻ 0.05 between the indicated groups.
Bands were detected by enhanced chemiluminescence using ECL Western blotting detection reagents (Amersham Bioscience, Piscataway, NJ). Band densitometry was quantified using Image J (National Institutes of Health, Bethesda, MD). Values were normalized to ␤-actin.
RNA silencing of TTF-1. TTF-1 silencing small inhibitory RNA oligoneucleotides, si#2 and si#4 (Invitrogen, Carlsbad, CA) were selected and administered as previously described (29) . This method of administration has been shown to effectively reduce TTF-1 expression level in the lung after pneumonectomy. Sequences of si#2 and si#4 were (5=-UUGAAACGUCGCUCGAGCUCGUACA-3=) and (5=-GCUACAA-GAUGAAGCGCCGGCUAA-3=), respectively. Thirty-five milligrams per kilogram of each inhibitory RNA was coadministered intranasally with DCI.
Exercise tests. Exercise function was tested using wheel-running tests (wheel circumference 75 cm) as an indirect index of lung function after pneumonectomy (23) . Before each test, the mice were adapted to the wheel by ϳ200 rounds of voluntary wheel running. First, as an index of forced exercise, the mouse was placed on the wheel, and the wheel was manually spun at one round per second. This was continued until the mouse was unable to cope and was spun with the wheel, and the number of rounds was recorded. This was repeated 3 times with 5-min breaks in between, and was averaged. Next, after a 30-min break, as an index of semivoluntary exercise, the mouse was placed on the wheel, and the number of rounds spun in 5 min was recorded. The mouse was facilitated to run by touching on the tail if it stood still for longer than 5 s. Measurements were taken before pneumonectomy (day 0), and on day 2, day 7, and day 14 after pneumonectomy and respective material administration. The NoTx group did not receive any treatment or surgery.
Statistical analysis. Data are expressed as means Ϯ SD. Comparisons between groups were done using Mann-Whitney U-test (StatView; Abacus, Berkeley, CA). Body weight and exercise tests were compared within groups using paired t-test (StatView; Abacus). Other comparisons within groups were done using Mann-Whitney U-test since the animals were killed for respective time point measurements. P values less than 0.05 were considered to be statistically significant.
RESULTS

Lung volume and lung weight measurements.
The body weight of the mice tended to increase within each group during the period of the experiment reflecting animal growth. It was reduced in the PNXϩDCI (n ϭ 5) and PNXϩINF (n ϭ 5) groups compared with the NoTx (n ϭ 5) group beyond day 2, but statistical significance was not reached. The body weight of the mice did not differ significantly between the PNXϩDCI group and the PNXϩINF group throughout the experiment period (Fig. 1A) . Therefore, it was considered feasible to compare weight-based indices between these groups.
The residual right LV and LVI were increased significantly beyond day 2 in both the PNXϩDCI (n ϭ 5 at each time point) group and the PNXϩINF (n ϭ 5 at each time point) group compared with the NoTx (n ϭ 5 at each time point) group. Within the PNXϩDCI group and the PNXϩINF group, there were no statistically different increases beyond day 2. There was no statistical difference between the PNXϩDCI group and the PNXϩINF group (Fig. 1, B and C) .
In contrast to the changes in LV and LVI, the residual right LDW and LDWI was significantly increased in the PNXϩDCI (n ϭ 5 at each time point) group compared with the PNXϩINF (n ϭ 5 at each time point) group and the NoTx (n ϭ 5 at each time point) group beyond day 2 (Fig. 1, D and E) . The magnitude of increase in LDWI in the PNXϩINF group was similar to the previous data on left pneumonectomy alone (31). The LWWI also showed a similar tendency, although the difference between the PNXϩDCI (n ϭ 5 at each time point) group and the PNXϩINF (n ϭ 5 at each time point) reached statistical significance only on day 28 (Fig. 1F) .
The effect of DCI dosage on LDWI was also evaluated. The LDWI at day 14 was compared between different dosages (n ϭ 5 in each group) (Fig. 1G) . The twofold dose did not induce further increase in LDWI, while one-half or one-quarter dosage attenuated the increase in LDWI. Hence, the dosage used in this study was considered to be most suitable within the dosages evaluated, at least in this particular model. DCI administration to mice without pneumonectomy did not induce any changes in LDWI.
Western blot analysis. Western blot analysis showed that TTF-1 expression in the residual right lung at day 2 was significantly increased in the PNXϩDCI group compared with pneumonectomy only (PNX group), the PNXϩINF group or the NoTx group (Fig. 2A) . We also concomitantly administered TTF-1 inhibitory RNAs (TTF-1 siRNAs) with DCI after pneumonectomy. The increase in LDWI by DCI administration was not affected by coadministration of TTF-1 siRNAs at day 2 (n ϭ 5 in each group) but was significantly suppressed at day 7 by TTF-1 siRNAs (n ϭ 5 in each group) (Fig. 2B) .
Morphological analyses. On histology, the alveoli appeared to be smaller in the PNXϩDCI group compared with the PNXϩINF group or the NoTx group at day 7 (Fig. 3A) . Morphological analyses showed that the number of alveoli per field of view was significantly increased in the PNXϩDCI group compared with the PNXϩINF group and the NoTx group throughout the experiment (Fig. 3B) . The average traced area of a single alveolus on histology was significantly decreased in the PNXϩDCI group compared with the PNXϩINF group and the NoTx group beyond 7 days (Fig. 3C) . The traced total alveolar area per field was significantly increased in the PNXϩDCI group compared with the PNXϩINF group and the NoTx group beyond 2 days (Fig. 3D) . The calculated surface area of the alveoli per volume of lung was also significantly increased in the PNXϩDCI group compared with the PNXϩINF group and the NoTx group at day 28 (Fig. 3E) .
Transpulmonary pressure measurements. The changes in transpulmonary pressure at day 14 was not significantly different between PNX (n ϭ 5), PNXϩINF (n ϭ 5), and the PNXϩDCI (n ϭ 5) groups (Fig. 4) . The calculated static compliance was also not statistically different between groups [PNX, PNXϩINF, and PNXϩDCI groups, 186.8 Ϯ 8.5, 190.8 Ϯ 6.8, and192.4 Ϯ 5.0, 10 Ϫ3 ml/cm H 2 O, respectively (P Ͼ 0.05)]. Exercise tests. General appearance, movement, and feeding behavior were similar between the PNXϩDCI group and the PNXϩINF group throughout the experiment period. Forced wheel running (n ϭ 4 in each group) at day 2 was significantly reduced in both groups compared with day 0. Recovery was seen beyond day 7 in the PNXϩDCI group but not in the PNXϩINF group (Fig. 5A) . Semivoluntary wheel running at day 2 tended to be reduced in both PNXϩDCI and PNXϩINF groups compared with day 0. Recovery was seen at day 7 in both groups without statistically significant differences. At day 14, the PNXϩDCI group and the NoTx group showed significantly increased semivoluntary wheel running compared with their respective day 0 values, presumably reflecting adaptation to wheel running, but the PNXϩINF group remained at a similar level as day 7. The difference at day 14 was significant between the PNXϩDCI group and the PNXϩINF group (Fig. 5B) .
DISCUSSION
In the present study, compensatory lung growth was modestly but significantly facilitated by airway administration of DCI, as indicated by the increase in LDW and LDWI. Morphological analyses suggested that DCI administration increased the number alveoli, made each of them smaller, and produced a net increase in the total alveolar area per field and the calculated surface area of the alveoli per volume of lung. Similar findings have been reported with retinoic acid (4, 21, 22) and estrogen (19, 20) . These findings may merely represent an imbalance between septation and septal cell proliferation, but it is also possible that DCI administration reduced lung elasticity. To this end, at least morphologically, there were no apparent indications of atelectasis, pleural thickening, septal thickening, or inflammation in the PNXϩDCI group. There was also no significant difference between the PNXϩINF group and the PNXϩDCI group in transpulmonary pressure at day 14. Therefore, the spatial constraint due to the predetermined volume of the chest cavity, which presumably resulted in the lack of significant increase in LVI, may A: Western blot analysis showed that thyroid transcription factor 1 (TTF-1) expression in the residual right lung at day 2 was significantly increased in the PNXϩDCI group compared with PNX only (PNX group), PNXϩINF group, or the NoTx group. The NoTx group and the respective ␤-actin is from a different gel. Band densitometry was quantified using Image J. Values were normalized to ␤-actin. *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups. B: increase in right LDWI by DCI administration after left pneumonectomy was not affected by coadministration of TTF-1 inhibitory RNAs (TTF-1 siRNAs), si#2, and si#4, at day 2 (n ϭ 5 in each group) but was significantly suppressed at day 7 by both sequences of TTF-1 siRNAs (n ϭ 5 in each group). *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups.
at least, in part, be the reason for these findings. Since morphological analyses were carried out in fixed specimens, it is also not possible to completely rule out the possibility that the fixation-induced shrinkage may have been different among groups. Further studies looking into the extracellular matrix components may resolve some of these issues, but collectively, the data suggest that the increase in LDWI was primarily due to the increase in the number of alveoli. If so, increased number of small alveoli may have actually augmented lung function within a fixed lung volume (19) . To Fig. 3 . Morphological findings. A: on morphology at day 7, the alveoli appeared to be smaller in the PNXϩDCI group compared with the PNXϩINF group or the NoTx group. Hematoxylin-and-eosin staining, scale bar 100 m. B: on morphological analysis, the number of alveoli per field of view was significantly increased in the PNXϩDCI (n ϭ 5, 25 fields for each time point) group compared with the PNXϩINF (n ϭ 5; 25 fields for each time point) group and the NoTx (n ϭ 5; 25 fields for each time point) group throughout the experiment. C: average traced area of a single alveolus on morphology was significantly decreased in the PNXϩDCI (n ϭ 5; 25 fields for each time point) group compared with the PNXϩINF (n ϭ 5; 25 fields for each time point) group, and the NoTx (n ϭ 5; 25 fields for each time point) group beyond 7 days. D: average total alveolar area per field on morphology was significantly increased in the PNXϩDCI (n ϭ 5; 25 fields for each time point) group compared with the PNXϩINF (n ϭ 5; 25 fields for each time point) group and the NoTx (n ϭ 5; 25 fields for each time point) group beyond 2 days. E: calculated surface area of the alveoli per volume of lung was significantly increased in the PNXϩDCI (n ϭ 5; 25 fields for each time point) group compared with the PNXϩINF (n ϭ 5; 25 fields for each time point) group and the NoTx (n ϭ 5; 25 fields for each time point) group beyond day 14. *P Ͻ 0.05 vs. NoTx group, **P Ͻ 0.05 between the indicated groups. this end, exercise capability, particularly forced exercise, which has been reported to reflect lung function (23) , was better sustained in the PNXϩDCI group compared with the PNXϩINF group, although it is possible that factors other than lung function may also have contributed to this difference. The results of the semivoluntary wheel-running test, at least in part, rules out the possibility that DCI administration caused alterations in spontaneous activity of mice, which may have influenced the results of the exercise tests. To this end, more detailed specific lung function tests are required.
Glucocorticoids potentially induce developmental lung growth (1) but is reported to have no apparent effect on compensatory lung growth by systemic administration (25) . Induction of cAMP has been shown to facilitate fetal lung maturation (2) , and in combination with dexamethasone, this facilitation has been shown to be synergistic (8) . The exact mechanism of this synergy remains unclear, and furthermore, the effects of glucocorticoids on developmental and postnatal lung growth seem to be context dependent. Developmental, postnatal, and postpneumonectomy compensatory lung growth may be regulated through different pathways although not mutually exclusive. Hence, it is possible that glucocorticoids and cAMP, individually and in combination, may act differently on each of the lung growth processes. Caution in the use of dexamethasone may be required since prolonged systemic administration of glucocorticoids, particularly at high doses, are reported to be detrimental to postnatal lung growth (6, 26) . Although the combined effects of the components of DCI may be substantially different from the effects of glucocorticoids alone, it is nevertheless encouraging that in the present study, the effect of a single administration of DCI was sustained for at least 28 days. Although we have not done any pharmacokinetic studies, it is unlikely that the effect of DCI per se was sustained throughout this period, suggesting that facilitation of initial stimuli for compensatory lung growth is important rather than its maintenance. Therefore, prolonged administration may not be necessary. Furthermore, administration of DCI without pneumonectomy did not demonstrate any overt effects (data not shown), suggesting that DCI only augments compensatory lung growth. To this end, the optimal timing of DCI administration in relation to pneumonectomy, along with the potential duration of action of DCI is considered to be important and requires further study.
In the present study, we used INF as a vehicle since it is in clinical use as a surfactant supplement and is experimentally Fig. 5 . Exercise tests as indirect indices of lung function. A: forced wheel running at day 0, prior to pneumonectomy, did not differ significantly between groups (n ϭ 4 in each group). Forced wheel running at day 2 was significantly reduced in both PNXϩDCI and PNXϩINF groups compared with the respective values at day 0. Recovery was seen beyond day 7 in the PNXϩDCI group but not in the PNXϩINF group. *P Ͻ 0.05 vs. respective day 0 values, **P Ͻ 0.05 between the indicated groups. B: semivoluntary wheel running at day 2 (n ϭ 4 in each group) tended to be reduced in both PNXϩDCI and PNXϩINF groups compared with day 0. Recovery was seen at day 7 in both groups without statistically significant differences. At day 14, the PNXϩDCI group and the NoTx group were significantly increased compared with their respective day 0 values, presumably reflecting adaptation to wheel running, but the PNXϩINF group remained at a similar level as day 7. The difference at day 14 was significant between the PNXϩDCI group and the PNXϩINF group. *P Ͻ 0.05 vs. respective day 0 and day 2 values, **P Ͻ 0.05 between the indicated groups. Fig. 4 . Transpulmonary pressure measurements were made using a water manometer at increments of 0.1 ml. The curve shape was not significantly different between the PNX group (n ϭ 5), PNXϩINF group (n ϭ 5) and the PNXϩDCI group (n ϭ 5).
reported to facilitate the movement of coadministered materials into the airway from the nasal orifice (18) . Other surface-active materials may also be effective. The delivery of inhaled alltransretinoic acid has been previously reported in detail (17) , showing that airway administration is expected to be most efficient in delivering materials to the lung. However, it is possible that systemic concentration of DCI was also significantly elevated in this particular study, since at least a fraction of administered DCI was expected to be absorbed from the nasal mucosa, even with INF. Further delivery and pharmacokinetic studies are necessary to address these issues.
Growth factors such as epidermal growth factor (11), hepatocyte growth factor (27) , vascular endothelial growth factor (28) , and keratinocyte growth factor (13) , and a form of vitamin, retinoic acid (12) , have been reported to facilitate compensatory lung growth. Our previous study suggested the importance of TTF-1 in compensatory lung growth (31) . The results of the present study indicate that DCI administration augments the induction of TTF-1 after pneumonectomy in the lung in vivo. Although the effect of DCI is likely to be multifaceted, the induction of TTF-1 may, at least in part, be involved in the effects of DCI on facilitating compensatory lung growth, since concomitant administration of TTF-1 siRNAs suppressed the effects of DCI on day 7, although this effect was not apparent on day 2. It is possible that the induction of TTF-1 by DCI may have peaked earlier than day 2. Administration of siRNAs at earlier time points, namely before pneumonectomy, may, to some extent, clarify this issue. Further studies to specify the types of alveolar septal cells affected by DCI are also necessary.
To our knowledge, this is the first report of a material administered through the airway, which facilitates compensatory lung growth. Airway administration would be an ideal route of application in the clinic for materials that are expected to function in the lung. Furthermore, DCI may have advantages over the administration of growth factors in that it is a combination of materials that are clinically accessible and that it is also expected to be more acceptable in terms of cost. Although still preliminary, DCI with further modifications may provide a therapeutic treatment to potentially augment residual lung function after resection.
